Bayer Pharmaceuticals is currently settling claims. However, it is important to select a reputable law firm to make sure your case is handled properly.
Orlando, FL (PRWEB) June 21, 2012
The Yaz Resource Center, a patient advocacy group, is alerting women who have suffered side effects after taking the birth control drugs Yaz and Yasmin that Bayer Pharmaceuticals is currently settling claims. However, it is important to select a reputable law firm to make sure your case is handled properly.
In 2009, The British Medical Journal published studies from Denmark and the Netherlands linking the chemicals in Yaz to blood clots. In October, 2011 the FDA also released data of more than 825,000 women taking oral contraceptives which showed drugs like Yaz could cause up to a 74% increased risk of developing blood clots.
As news spread, thousands of women who had taken Yaz filed injury claims for blood clot-related conditions such as stroke, Deep Vein Thrombosis, and Pulmonary Embolism.
According to a federal Multi-District Litigation court established in the Southern District of Illinois to handle Yaz cases, nearly 12,000 people have filed a Yaz lawsuit. The formal case style is Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100).
Bloomberg News originally reported on April 13, 2012 that Bayer would settle 500 of the lawsuits at approximately $220,000 per case. The company has now reported in its Stockholders’ Newsletter for the first quarter that it has paid $142 million in settlements, at an average of about $218,000 a case.
With news of settlements growing, the Yaz Resource Center has received calls from patients who have been promised quick settlements and lawsuit proceeds within days.
The Yaz Resource Center cautions patients that while Yaz settlements are available, only certain law firms will be able to secure settlement of their cases. It typically takes months for medical records and documents to be approved before proceeds are received. Anyone who is told otherwise should be suspicious.
Patients who settle a Yaz lawsuit may also be offered an advancement or loan on their case, however, this should be avoided if possible as these types of loans often charge high interest rates of 30% or more.
The Resource Center only recommends certain lawyers who have already settled Yaz lawsuits. For more information on the research, side effects and litigation related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.